Skip to main content

Caribou Biosciences, Inc.

CRBU
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001619856

No open-market purchases or sales by Caribou Biosciences, Inc. insiders were filed in the last 90 days; 137 institutions reported holding it in 13F filings for Q2 2026, worth $84.8M in total; Maverick Capital is the only superinvestor holding it.

13F holders, Q1 2025

Institutional positions in Caribou Biosciences, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
131
0 vs. Q4 2024
Shares held
50.3M
−7.68M (−13.3%) vs. Q4 2024
Total value
$45.8M
−$46.8M (−50.5%) vs. Q4 2024
New holders
19
35 more added
Sold out
19
42 more reduced

2 institutions that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q4 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting CRBU on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2025: 131 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 88 institutionsQ4 2021: 93 institutionsQ1 2022: 104 institutionsQ2 2022: 120 institutionsQ3 2022: 113 institutionsQ4 2022: 133 institutionsQ1 2023: 126 institutionsQ2 2023: 121 institutionsQ3 2023: 126 institutionsQ4 2023: 144 institutionsQ1 2024: 151 institutionsQ2 2024: 140 institutionsQ3 2024: 129 institutionsQ4 2024: 133 institutionsQ1 2025: 131 institutionsQ2 2025: 129 institutionsQ3 2025: 117 institutionsQ4 2025: 124 institutionsQ1 2026: 137 institutionsQ2 2026: 137 institutions
Value heldQ1 2025: $45.8M
Q1 2021: $0Q2 2021: $0Q3 2021: $704.7MQ4 2021: $464.7MQ1 2022: $313.2MQ2 2022: $203.0MQ3 2022: $456.8MQ4 2022: $273.8MQ1 2023: $238.3MQ2 2023: $185.5MQ3 2023: $338.5MQ4 2023: $395.8MQ1 2024: $343.0MQ2 2024: $87.6MQ3 2024: $103.1MQ4 2024: $93.1MQ1 2025: $45.8MQ2 2025: $51.2MQ3 2025: $87.0MQ4 2025: $58.8MQ1 2026: $71.3MQ2 2026: $84.8M
Institutions holding CRBU and their total value by quarter
QuarterHoldersValue
Q2 2026137$84.8M
Q1 2026137$71.3M
Q4 2025124$58.8M
Q3 2025117$87.0M
Q2 2025129$51.2M
Q1 2025131$45.8M
Q4 2024133$93.1M
Q3 2024129$103.1M
Q2 2024140$87.6M
Q1 2024151$343.0M
Q4 2023144$395.8M
Q3 2023126$338.5M
Q2 2023121$185.5M
Q1 2023126$238.3M
Q4 2022133$273.8M
Q3 2022113$456.8M
Q2 2022120$203.0M
Q1 2022104$313.2M
Q4 202193$464.7M
Q3 202188$704.7M
Q2 20210$0
Q1 20210$0

Institutions, Q1 2025

Shares, value and share of portfolio for each institution holding Caribou Biosciences, Inc.; share changes are against Q4 2024.

Institutions holding CRBU in Q1 2025
InstitutionSharesValue% of portfolioChange in sharesAction
Ameriprise Financial Inc408,058$372.6K0.00%00.0%Unchanged
Standard Life Aberdeen plc411,144$375.4K0.00%+229,657+126.5%Added
Green Alpha Advisors, LLC432,325$394.8K0.42%+251,271+138.8%Added
Elmwood Wealth Management, Inc.468,240$427.6K0.18%−1,557,500−76.9%Reduced
72 Investment Holdings, LLC474,067$432.9K1.22%00.0%Unchanged
Morgan Stanley482,764$440.8K0.00%−2,266,833−82.4%Reduced
AQR Capital Management LLC525,878$480.2K0.00%+463,391+741.6%Added
UBS Group AG582,878$532.2K0.00%+186,511+47.1%Added
Cambridge Investment Research Advisors, Inc.612,412$559.0K0.00%+612,412New
Maverick Capital LtdSuperinvestorMaverick Capital652,542$595.8K0.01%00.0%Unchanged
Northern Trust Corp662,043$604.5K0.00%−52,694−7.4%Reduced
Charles Schwab Investment Management Inc727,222$664.0K0.00%−18,504−2.5%Reduced
Pale Fire Capital SE786,722$718.4K0.09%+52,518+7.2%Added
JPMorgan Chase & Co804,554$734.6K0.00%−1,691,368−67.8%Reduced
Millennium Management LLC821,051$749.7K0.00%−38,774−4.5%Reduced
Goldman Sachs Group Inc822,840$751.3K0.00%−247,696−23.1%Reduced
Two Sigma Investments, LP981,298$896.0K0.00%−137,398−12.3%Reduced
Bank of America Corp1,100,465$1.00M0.00%−668,828−37.8%Reduced
Dimensional Fund Advisors LP1,384,669$1.26M0.00%−347,709−20.1%Reduced
Jacobs Levy Equity Management, Inc1,442,121$1.32M0.01%+234,052+19.4%Added
FMR LLC1,460,098$1.33M0.00%−187,107−11.4%Reduced
Two Sigma Advisers, LP1,507,200$1.38M0.00%+36,500+2.5%Added
State Street Corp1,641,181$1.50M0.00%−16,380−1.0%Reduced
Geode Capital Management, LLC2,053,929$1.88M0.00%+81,534+4.1%Added
Schonfeld Strategic Advisors LLC2,351,582$2.15M0.01%+238,310+11.3%Added
PFM Health Sciences, LP2,506,435$2.29M0.18%−1,370,027−35.3%Reduced
Kynam Capital Management, LP3,269,147$2.99M0.26%+863,000+35.9%Added
Vanguard Group Inc4,522,032$4.13M0.00%−43,413−1.0%Reduced
Pfizer Inc4,690,431$4.28M0.86%00.0%Unchanged
BlackRock, Inc.6,346,438$5.79M0.00%−217,751−3.3%Reduced
DekaBank Deutsche Girozentrale130,000––00.0%Unchanged
FIL Ltd0$00.00%−860,666−100.0%Sold out
Lynx1 Capital Management LP0$00.00%−680,189−100.0%Sold out
American Century Companies Inc0$00.00%−159,822−100.0%Sold out
Verition Fund Management LLC0$00.00%−140,101−100.0%Sold out
Balboa Wealth Partners0$00.00%−55,277−100.0%Sold out
Bank of Montreal0$00.00%−46,728−100.0%Sold out
Diametric Capital, LP0$00.00%−26,224−100.0%Sold out
MetLife Investment Management0$00.00%−24,404−100.0%Sold out
Prudential Financial Inc0$00.00%−20,772−100.0%Sold out
Centric Wealth Management0$00.00%−16,847−100.0%Sold out
Franklin Resources Inc0$00.00%−12,411−100.0%Sold out
Beaumont Capital Management, LLC0$00.00%−11,825−100.0%Sold out
Engineers Gate Manager LP0$00.00%−11,294−100.0%Sold out
Signaturefd, LLC0$00.00%−750−100.0%Sold out
Smartleaf Asset Management LLC0$00.00%−552−100.0%Sold out
Skopos Labs, Inc.0$00.00%−362−100.0%Sold out
Point72 Asia (Singapore) Pte. Ltd.0$00.00%−19−100.0%Sold out
NBC Securities, Inc.0$00.00%−2−100.0%Sold out
Lazard Asset Management LLC0$00.00%−298−100.0%Sold out
Nuveen Asset Management, LLC––––Not filed
Global Retirement Partners, LLC––––Not filed